ESMO 2026 Guideline: Redefining the Management of Metastatic Colorectal Cancer
oncodaily - Metastatic colorectal cancer (mCRC) represents a complex and biologically diverse disease in which treatment decisions increasingly depend on molecular characteristics, disease burden, and patient-specific factors. While therapeutic options have expanded …
AI Summary: The European Society for Medical Oncology released updated clinical practice guidelines for metastatic colorectal cancer, redefining diagnostic pathways, systemic therapy sequencing, and follow‑up standards. The guidance incorporates recent targeted and immunotherapy evidence to recommend practical treatment algorithms, prompting oncology centers to update protocols and payers to reassess coverage as clinicians translate recommendations into routine care.
Related Stories
Perioperative advances reshape muscle‑invasive bladder cancer care / 5 wks
Two‑year lenalidomide maintenance shows no survival penalty / 6 wks
Ovarian suppression with tamoxifen cuts recurrence in premenopausal breast cancer / 7 wks
Journal retracts study claiming morning immunotherapy benefit / 2 months
Perioperative apalutamide plus ADT improves high‑risk prostate outcomes / 2 months
Small study reports 100% one‑year survival after lung transplant / 7 wks
High‑dose targeted radiation shows promise for huge bile duct tumors / 4 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Health IT, Avian Influenza, Rural Health, Medicaid and look for the RSS link.
StackHealth Time Machine